33,391 Shares in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Acquired by Caisse Des Depots ET Consignations

Caisse Des Depots ET Consignations purchased a new stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA) during the fourth quarter, HoldingsChannel reports. The institutional investor purchased 33,391 shares of the real estate investment trust’s stock, valued at approximately $578,000.

Several other institutional investors also recently bought and sold shares of SBRA. JPMorgan Chase & Co. boosted its position in Sabra Health Care REIT by 222.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock worth $183,996,000 after purchasing an additional 6,819,919 shares during the period. Wellington Management Group LLP grew its position in Sabra Health Care REIT by 736.5% in the third quarter. Wellington Management Group LLP now owns 2,396,835 shares of the real estate investment trust’s stock valued at $44,605,000 after acquiring an additional 2,110,307 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Sabra Health Care REIT by 324.3% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,404,576 shares of the real estate investment trust’s stock valued at $26,139,000 after purchasing an additional 1,073,530 shares during the period. Thrivent Financial for Lutherans lifted its position in shares of Sabra Health Care REIT by 95.9% during the fourth quarter. Thrivent Financial for Lutherans now owns 1,816,217 shares of the real estate investment trust’s stock worth $31,457,000 after purchasing an additional 888,908 shares in the last quarter. Finally, FMR LLC boosted its stake in shares of Sabra Health Care REIT by 89.7% in the third quarter. FMR LLC now owns 1,599,532 shares of the real estate investment trust’s stock valued at $29,767,000 after purchasing an additional 756,418 shares during the period. 99.40% of the stock is currently owned by hedge funds and other institutional investors.

Sabra Health Care REIT Stock Performance

Sabra Health Care REIT stock opened at $17.38 on Friday. The company has a market cap of $4.13 billion, a PE ratio of 32.79, a P/E/G ratio of 1.97 and a beta of 1.27. Sabra Health Care REIT, Inc. has a 12 month low of $13.31 and a 12 month high of $20.03. The company has a fifty day moving average price of $16.82 and a two-hundred day moving average price of $17.67. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.36. The business had revenue of $182.35 million during the quarter, compared to the consensus estimate of $178.01 million. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. Research analysts expect that Sabra Health Care REIT, Inc. will post 1.45 earnings per share for the current year.

Sabra Health Care REIT Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.90%. The ex-dividend date was Friday, February 14th. Sabra Health Care REIT’s payout ratio is 226.42%.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Mizuho reiterated a “neutral” rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th. JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a research note on Tuesday, January 7th. Finally, Truist Financial upped their target price on Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “hold” rating in a research report on Tuesday, March 18th. Three equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $19.33.

Sabra Health Care REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.